Literature DB >> 20524041

Malignant ganglioglioma: case report and review of literature.

Ryan DeMarchi1, Suzy Abu-Abed, David Munoz, R Loch Macdonald.   

Abstract

We report a case of de novo malignant ganglioglioma. A 61-year-old male presented with a 12-day history of headaches and general malaise. Pre-operative magnetic resonance imaging revealed an irregular enhancing mass in the left temporal lobe with associated dural enhancement and subacute subdural hematoma. The findings at surgery were of a vascular tumor intimately involving the surrounding white matter, with central necrosis. Histological and immunohistochemical studies showed an anaplastic ganglioglioma with World Health Organization grade IV characteristics. Gangliogliomas of the central nervous system are rare and are typified by a pediatric predilection and indolent behavior. A review of the de novo anaplastic and malignant gangliogliomas is presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524041     DOI: 10.1007/s11060-010-0248-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  39 in total

Review 1.  Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas.

Authors:  C S Rumana; A B Valadka
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

2.  Ganglioglioma: an ultrastructural and immunohistochemical study.

Authors:  T Hirose; B W Scheithauer; M B Lopes; H A Gerber; H J Altermatt; S R VandenBerg
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

3.  Primary spinal anaplastic ganglioglioma.

Authors:  H Selim Karabekir; Canan Balci; Cigdem Tokyol
Journal:  Pediatr Neurosurg       Date:  2006       Impact factor: 1.162

Review 4.  Ganglioglioma presenting as a meningioma: case report and review of the literature.

Authors:  Khawar Siddique; Michael Zagardo; Meena Gujrati; William Olivero
Journal:  Neurosurgery       Date:  2002-05       Impact factor: 4.654

5.  Diffuse leptomeningeal involvement by a ganglioglioma in a child. Case report.

Authors:  M R Wacker; P H Cogen; J E Etzell; L Daneshvar; R L Davis; M D Prados
Journal:  J Neurosurg       Date:  1992-08       Impact factor: 5.115

Review 6.  Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: a study of 60 patients with intracranial tumors.

Authors:  R A Prayson; K Khajavi; Y G Comair
Journal:  J Neuropathol Exp Neurol       Date:  1995-07       Impact factor: 3.685

7.  Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery.

Authors:  So-Hyang Im; Chun Kee Chung; Byung-Kyu Cho; Kyu-Chang Wang; In-Kyu Yu; In Chan Song; Gi Jeong Cheon; Dong Soo Lee; Na-Rae Kim; Je G Chi
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

8.  Central nervous system neoplasm in a young man with Martin-Bell syndrome--fra(X)-XLMR.

Authors:  L Rodewald; D C Miller; L Sciorra; G Barabas; M L Lee
Journal:  Am J Med Genet       Date:  1987-01

9.  Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Otmar D Wiestler; Johannes Schramm
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

10.  Ganglioglioma: 13 years of experience.

Authors:  S F Haddad; S A Moore; A H Menezes; J C VanGilder
Journal:  Neurosurgery       Date:  1992-08       Impact factor: 4.654

View more
  15 in total

1.  Freiburg neuropathology case conference: cystic mass lesions of the temporal and occipital lobes in an elderly patient.

Authors:  C A Taschner; O Staszewski; M Pinsker; S El Shikh; M Prinz
Journal:  Clin Neuroradiol       Date:  2011-11       Impact factor: 3.649

2.  Impact of surgery, adjuvant treatment, and other prognostic factors in the management of anaplastic ganglioglioma.

Authors:  Supriya Mallick; Rony Benson; Wineeta Melgandi; Prashanth Giridhar; G K Rath
Journal:  Childs Nerv Syst       Date:  2018-03-29       Impact factor: 1.475

3.  Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry.

Authors:  Michael H Chan; B K Kleinschmidt-Demasters; Andrew M Donson; Diane K Birks; Nicholas K Foreman; Sarah Z Rush
Journal:  Pediatr Blood Cancer       Date:  2012-06-15       Impact factor: 3.167

4.  Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database.

Authors:  Senthil K Selvanathan; Salah Hammouche; Heidi J Salminen; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2011-05-29       Impact factor: 4.130

5.  Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status.

Authors:  Aaron J Lindsay; Sarah Z Rush; Laura Z Fenton
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

Review 6.  Anaplastic ganglioglioma: a report of three cases and review of the literature.

Authors:  John Thomas Lucas; Andrew Jonathan Huang; Ryan T Mott; Glenn J Lesser; Stephen Bradley Tatter; Michael David Chan
Journal:  J Neurooncol       Date:  2015-04-11       Impact factor: 4.130

7.  Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database.

Authors:  Louis-Marie Terrier; Luc Bauchet; Valérie Rigau; Aymeric Amelot; Sonia Zouaoui; Isabelle Filipiak; Agnès Caille; Fabien Almairac; Marie-Hélène Aubriot-Lorton; Anne-Marie Bergemer-Fouquet; Eric Bord; Philippe Cornu; Alain Czorny; Phong Dam Hieu; Bertrand Debono; Marie-Bernadette Delisle; Evelyne Emery; Walid Farah; Guillaume Gauchotte; Catherine Godfraind; Jacques Guyotat; Bernard Irthum; Kevin Janot; Pierre-Jean Le Reste; Dominique Liguoro; Hugues Loiseau; Guillaume Lot; Vincent Lubrano; Emmanuel Mandonnet; Philippe Menei; Philippe Metellus; Serge Milin; Bertrand Muckenstrum; Pierre-Hugues Roche; Audrey Rousseau; Emmanuelle Uro-Coste; Anne Vital; Jimmy Voirin; Michel Wager; Marc Zanello; Patrick François; Stéphane Velut; Pascale Varlet; Dominique Figarella-Branger; Johan Pallud; Ilyess Zemmoura
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

8.  Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.

Authors:  Andrew M Donson; Bette K Kleinschmidt-DeMasters; Dara L Aisner; Lynne T Bemis; Diane K Birks; Jean M Mulcahy Levy; Amy A Smith; Michael H Handler; Nicholas K Foreman; Sarah Z Rush
Journal:  Brain Pathol       Date:  2013-12-23       Impact factor: 6.508

9.  Accuracy of distinguishing between dysembryoplastic neuroepithelial tumors and other epileptogenic brain neoplasms with [¹¹C]methionine PET.

Authors:  Sylvain Rheims; Sebastià Rubi; Sandrine Bouvard; Emilien Bernard; Nathalie Streichenberger; Marc Guenot; Didier Le Bars; Alexander Hammers; Philippe Ryvlin
Journal:  Neuro Oncol       Date:  2014-03-05       Impact factor: 12.300

10.  Clinical and prognostic features of adult patients with gangliogliomas.

Authors:  Shlomit Yust-Katz; Mark Daniel Anderson; Diane Liu; Jimin Wu; Ying Yuan; Adriana Olar; Greg N Fuller; Paul D Brown; John F de-Groot
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.